Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

143.97 +7.35 (+5.38%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

99 100 Next >

Which S&P500 stocks are the most active on Friday? ↗

February 14, 2025

Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest and driving market movements.

Via Chartmill

Moderna (MRNA) Q4 2024 Earnings Call Transcript ↗

February 14, 2025

MRNA earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What's Driving Markets Friday? ↗

February 14, 2025

Stocks are headed for weekly gains, with the Dow Jones dipping slightly and the S&P 500 and Nasdaq trading just above the flatline Friday.

Via Benzinga

Topics Stocks

Discover which S&P500 stocks are making waves on Friday. ↗

February 14, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Will Moderna's Retained 2025 Outlook Bolster Its Depressed Shares? ↗

February 14, 2025

The company came up with a mixed fourth-quarter report, but kept its outlook for 2025.

Via Investor's Business Daily

What the Options Market Tells Us About Moderna ↗

February 11, 2025

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

February 14, 2025

Via Benzinga

Moderna’s Q4 Losses Worse Than Feared, But Revenue Beat And Cost Cuts Boost Stock — Retail Sentiment Follows ↗

February 14, 2025

CEO Stéphane Bancel said the company remains focused on driving sales and achieving up to 10 product approvals by 2027, as well as removing nearly $1 billion in costs by the end of this year.

Via Stocktwits

Moderna's Q4 Loss Wider Than Expected ↗

February 14, 2025

The biopharma reported disappointing fourth-quarter results, missing bottom line estimates amid a steep decline in COVID-19 vaccine sales.

Via The Motley Fool

Which S&P500 stocks are moving before the opening bell on Friday? ↗

February 14, 2025

Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.

Via Chartmill

Applied Materials, Informatica, Clearwater Paper And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

February 14, 2025

Via Benzinga

Moderna Stock: A Deep Dive Into Analyst Perspectives (11 Ratings) ↗

February 11, 2025

Via Benzinga

Moderna Struggles With Declining Q4 COVID Vaccine Sales, Stock Slides ↗

February 14, 2025

Moderna reported a Q4 EPS loss of $2.91, missing estimates, with revenue down 66% YoY to $966 million. The company reaffirmed 2025 guidance and cost-cutting plans.

Via Benzinga

Moderna’s (NASDAQ:MRNA) Q4 Earnings Results: Revenue In Line With Expectations But Full-Year Sales Guidance Misses Expectations Significantly

February 14, 2025

Biotechnology company Moderna (NASDAQ:MRNA) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 65.6% year on year to $966 million. On the other hand, the company’s full-year revenue...

Via StockStory

Topics Artificial Intelligence

Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates

February 14, 2025

Via ACCESS Newswire

Dow Jumps Over 300 Points Following Recent Inflation Data; Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone ↗

February 14, 2025

Via Benzinga

Topics Economy Stocks

Palo Alto Networks, Moderna And 3 Stocks To Watch Heading Into Friday ↗

February 14, 2025

Via Benzinga

US Stocks Set For A Volatile Start: Analyst Dismisses Chances Of 20%+ S&P 500 Gain For Third Year In A Row, But Says 'Investors Should Be Optimistic' ↗

February 14, 2025

U.S. stock futures traded close to the flatline on Friday after Tuesday's rally. Futures of all four benchmark indices were slightly lower.

Via Benzinga

Topics Stocks

Earnings Scheduled For February 14, 2025 ↗

February 14, 2025

Via Benzinga

Moderna Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗

February 14, 2025

Via Benzinga

Moderna Q4 Earnings Preview: COVID-19 Vaccine Sales, Bird Flu Vaccine Candidates On Watch ↗

February 13, 2025

Moderna is set to release its fourth-quarter earnings on Friday before the opening bell. Here's a look at what to expect in the report:

Via Benzinga

Robert F. Kennedy, Vaccine Skeptic, Confirmed As Trump's Secretary Of Health: Health Care Stocks To Watch ↗

February 13, 2025

The U.S. Senate voted on Thursday to confirm President Donald Trump's nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services.

Via Benzinga

Topics Government

Moderna (MRNA) Q4 Earnings Report Preview: What To Look For

February 13, 2025

Biotechnology company Moderna (NASDAQ:MRNA) will be announcing earnings results tomorrow before market open. Here’s what to expect.

Via StockStory

RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care. ↗

February 12, 2025

The Senate will vote Thursday on whether to put RFK Jr. in charge of health. It's unclear how he will impact biotech stocks.

Via Investor's Business Daily

10 Health Care Stocks With Whale Alerts In Today's Session ↗

February 11, 2025

Via Benzinga

Walmart To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

February 11, 2025

Via Benzinga

Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch ↗

February 10, 2025

A Nevada dairy worker who initially tested positive for bird flu is currently experiencing mild symptoms, including "pink eye."

Via Benzinga

US Stocks To Open On A Positive Note After A String Of Bad Mondays: Recent Dip Has 'Reached Its Low Point,' Says Technical Analyst ↗

February 10, 2025

U.S. stock futures rose on Monday following Friday's sharp fall as investors digest tariff updates and earnings reports.

Via Benzinga

Topics World Trade

2 Biotech Stocks to Buy Hand Over Fist in February ↗

February 09, 2025

Via The Motley Fool

Estee Lauder, Moderna And PayPal Are Among Top 10 Large Cap Losers Last Week (Feb 3-Feb 7): Are The Others In Your Portfolio? ↗

February 09, 2025

Skyworks Solutions, Estee Lauder, Venture Global, Neurocrine Biosciences, Moderna, Illumina, IDEX Corporation, PTC Inc, PayPal Holdings, Skechers U.S.A. and Avantor were worst performers, fell up to...

Via Benzinga

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.